Ad
Wednesday, 2 January 2019
Aurobindo Pharma to recall 80 lots of blood pressure medicine valsartan in the US
A U.S. unit of Indian generic drugmaker Aurobindo Pharma Ltd will recall 80 lots of medicines containing blood pressure drug valsartan that were found to have a probable cancer-causing impurity, according to the U.S. Food and Drug Administration.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment